BioSpace News Archive

FUJIFILM Irvine Scientific, Inc., a world leader in providing cell culture solutions for Life Science and Medical markets, today announced the expansion of its Armstrong R&D Center of Excellence at its headquarters in California.

Clinical studies demonstrate the considerable patient benefits of the vaginal natural orifice transluminal endoscopic surgery technique – a new, modern approach to vaginal surgery.

CTAD Conference -- AmyriAD – a biopharmaceutical company led by the development strategist who introduced the cognition enhancing medication Aricept® – today announced its leading candidate in the fight against Alzheimer’s Disease (AD), AD101, will enter Phase 3 trials in the second quarter of 2022.

Ryvu Therapeutics today announced third quarter 2021 financial results and a corporate update.

Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that it will present at the Jefferies London Healthcare Conference, which is taking place November 16-19, 2021.

Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today reported third quarter 2021 financial results.

Erasca, Inc., a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, reported financial results for the fiscal quarter ended September 30, 2021, and provided business updates.

F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the lives of patients with cancer, announced third quarter 2021 financial results and a corporate update.

Arcutis Biotherapeutics, Inc., a late-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology to address the urgent needs of patients living with immune-mediated dermatological diseases and conditions, announced that Arcutis management will participate in an upcoming investor conference in November.

X4 Pharmaceuticals, Inc., a leader in the discovery and development of novel CXCR4-targeted small molecule therapeutics to benefit people with diseases of the immune system, announced that management will participate in a fireside chat at Stifel’s Virtual Healthcare Conference on Wednesday, November 17, 2021.